Multimmune
1 known investors
multimmune develops cancer diagnostics and therapeutics ("theranostics") based on membrane Hsp70, a molecule expressed across many cancer types. Its work spans therapeutic interventions, drug targeting strategies, diagnostic tools, and imaging platforms within precision oncology.
Investors · 1
Frequently asked questions
- What does Multimmune do?
- multimmune develops cancer diagnostics and therapeutics ("theranostics") based on membrane Hsp70, a molecule expressed across many cancer types. Its work spans therapeutic interventions, drug targeting strategies, diagnostic tools, and imaging platforms within precision oncology.
- Who are Multimmune's investors?
- Multimmune's investors include Bayern Kapital.